ARTELO BIOSCIENCES, INC. Depreciation
ARTELO BIOSCIENCES, INC. (ARTL) reported Depreciation of $183 for the 9-month period ending 2021-05-31, per its 10-Q filed 2021-07-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2021-07-12
- ARTELO BIOSCIENCES, INC. depreciation for the quarter ending 2021-05-31 was $61.00, a 50.81% decline year-over-year.
- ARTELO BIOSCIENCES, INC. depreciation for the quarter ending 2021-02-28 was $62.00, a 50.00% decline year-over-year.
- ARTELO BIOSCIENCES, INC. depreciation for the quarter ending 2020-11-30 was $60.00, a 51.61% decline year-over-year.
- ARTELO BIOSCIENCES, INC. depreciation for the quarter ending 2020-08-31 was $128.00, a 0.79% increase year-over-year.
- ARTELO BIOSCIENCES, INC. depreciation for fiscal 2020 was $500.00, a 1.96% decline from fiscal 2019.
- ARTELO BIOSCIENCES, INC. depreciation for fiscal 2019 was $510.00, a 80.85% increase from fiscal 2018.
- ARTELO BIOSCIENCES, INC. depreciation for fiscal 2018 was $282.00.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2021-05-31 | $61.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | $123.00 derived: sum of 2 quarters · filed 2021-07-12 | $183.00 10-Q · filed 2021-07-12 | $311.00 derived: sum of 4 quarters · filed 2021-07-12 | |
| 2021-02-28 | $62.00 10-Q · filed 2021-04-13 | $122.00 10-Q · filed 2021-04-13 | $250.00 derived: sum of 3 quarters · filed 2021-04-13 | $374.00 derived: sum of 4 quarters · filed 2021-04-13 | |
| 2020-11-30 | $60.00 10-Q · filed 2021-01-14 | $188.00 derived: sum of 2 quarters · filed 2021-01-14 | $312.00 derived: sum of 3 quarters · filed 2021-01-14 | $436.00 derived: sum of 4 quarters · filed 2021-04-13 | |
| 2020-08-31 | $128.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $252.00 derived: sum of 2 quarters · filed 2020-11-04 | $376.00 derived: sum of 3 quarters · filed 2021-04-13 | $500.00 10-K · filed 2020-11-04 | |
| 2020-05-31 | $124.00 10-Q · filed 2020-07-13 | $248.00 derived: sum of 2 quarters · filed 2021-04-13 | $372.00 10-Q · filed 2021-07-12 | $499.00 derived: sum of 4 quarters · filed 2021-04-13 | |
| 2020-02-29 | $124.00 10-Q · filed 2021-04-13 | $248.00 10-Q · filed 2021-04-13 | $375.00 derived: sum of 3 quarters · filed 2021-04-13 | $618.00 derived: sum of 4 quarters · filed 2021-04-13 | |
| 2019-11-30 | $124.00 10-Q · filed 2021-01-14 | $251.00 derived: sum of 2 quarters · filed 2021-01-14 | $494.00 derived: sum of 3 quarters · filed 2021-01-14 | $564.00 derived: sum of 4 quarters · filed 2021-01-14 | |
| 2019-08-31 | $127.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $370.00 derived: sum of 2 quarters · filed 2020-11-04 | $440.00 derived: sum of 3 quarters · filed 2020-11-04 | $510.00 10-K · filed 2020-11-04 | |
| 2019-05-31 | $243.00 10-Q · filed 2020-07-13 | $313.00 derived: sum of 2 quarters · filed 2020-07-13 | $383.00 10-Q · filed 2020-07-13 | $416.00 derived: sum of 4 quarters · filed 2020-07-13 | |
| 2019-02-28 | $70.00 10-Q · filed 2020-04-13 | $140.00 10-Q · filed 2020-04-13 | $173.00 derived: sum of 3 quarters · filed 2020-04-13 | $246.00 derived: sum of 4 quarters · filed 2020-04-13 | |
| 2018-11-30 | $70.00 10-Q · filed 2020-01-14 | $103.00 derived: sum of 2 quarters · filed 2020-01-14 | $176.00 derived: sum of 3 quarters · filed 2020-01-14 | $250.00 derived: sum of 4 quarters · filed 2020-01-14 | |
| 2018-08-31 | $33.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | $106.00 derived: sum of 2 quarters · filed 2019-12-18 | $180.00 derived: sum of 3 quarters · filed 2019-12-18 | $282.00 10-K/A · filed 2019-12-18 | $290.00 10-K · filed 2018-11-29 |
| 2018-05-31 | $73.00 10-Q · filed 2019-07-15 | $147.00 derived: sum of 2 quarters · filed 2019-07-15 | $249.00 10-Q · filed 2019-07-15 | ||
| 2018-02-28 | $74.00 10-Q · filed 2019-04-15 | $146.00 10-Q · filed 2019-04-15 | |||
| 2017-11-30 | $72.00 10-Q · filed 2019-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |